INCYTE CORPORATION Deferred Tax Assets, Investments
INCYTE CORPORATION (INCY) had Deferred Tax Assets, Investments of $2.89 million as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInvestments · last filed 2026-02-10
- 2025-12-31: Deferred Tax Assets, Investments $2.89M.
- 2024-12-31: Deferred Tax Assets, Investments $6.70M.
- 2023-12-31: Deferred Tax Assets, Investments $42.98M.
- 2022-12-31: Deferred Tax Assets, Investments $54.66M.
| Period end | Deferred Tax Assets, Investments |
|---|---|
| 2025-12-31 | $2.89M 10-K · filed 2026-02-10 |
| 2024-12-31 | $6.70M 10-K · filed 2026-02-10 |
| 2023-12-31 | $42.98M 10-K · filed 2025-02-10 |
| 2022-12-31 | $54.66M 10-K · filed 2024-02-13 |
| 2021-12-31 | $34.73M 10-K · filed 2023-02-07 |
| 2020-12-31 | $25.97M 10-K · filed 2022-02-08 |
| 2019-12-31 | $14.90M 10-K · filed 2021-02-09 |
| 2018-12-31 | $23.62M 10-K · filed 2020-02-13 |
| 2017-12-31 | $12.24M 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |